ArticleJCO precision oncology2023

Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.

Lorenzo Gerratana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.